tiprankstipranks
TransCode Therapeutics (RNAZ)
NASDAQ:RNAZ
US Market

TransCode Therapeutics (RNAZ) Stock Investors

211 Followers
Based on 747,525 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold RNAZ
On average, investors allocate 0.00% of their portfolios to RNAZ
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 747,525 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding RNAZ

3.8%
Last 7
Days
5.6%
Last 30
Days
Percentages indicate the change in the number of portfolios holding RNAZ, out of 747,525 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

RNAZ Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,195 investors who made their portfolios public
The table shows changes in RNAZ in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

RNAZ Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Riot Platforms
5.15%
-0.53%
+0.54%
3.47B
Financial
ChargePoint Holdings
4.17%
-1.00%
-2.43%
833.60M
Consumer Cyclical
Marathon Digital Holdings
5.78%
-0.18%
+0.20%
6.75B
Financial
Plug Power
5.02%
-1.49%
-3.21%
1.87B
Industrials
PDD Holdings
4.99%
-1.29%
+1.71%
176.76B
Consumer Cyclical
UiPath
3.29%
-1.66%
-2.81%
6.90B
Technology
GE Aerospace
5.19%
-0.16%
+1.09%
174.18B
Industrials
Vertiv Holdings
4.52%
-0.68%
+1.83%
31.94B
Industrials
SoundHound AI, Inc Class A
5.08%
-0.07%
+0.89%
1.62B
Technology
Lucid Group
5.66%
-1.43%
-2.74%
8.08B
Consumer Cyclical
Based on the activity of 747,525 active portfolios
Open your Smart Portfolio

RNAZ Investor Analysis

RNAZ investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
52.6%
of RNAZ holders
are under 35
Average Segment Performance
Average P/E Ratio20.77
Beta7.15
Dividend Yield6.79%
RNAZ investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
15.8%
of RNAZ holders
are between 35–55
Average Segment Performance
Average P/E Ratio19.59
Beta11.22
Dividend Yield6.44%
RNAZ investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
31.6%
of RNAZ holders
are over 55
Average Segment Performance
Average P/E Ratio19.41
Beta3.84
Dividend Yield7.80%
Overview of age group and performance of RNAZ stock investors
See who invests in RNAZ according to age group and performance.

FAQ

How many retail Investors hold RNAZ?
<0.1% of TipRanks' retail investors hold RNAZ in their portfolios.
    What is RNAZ Investor Sentiment?
    RNAZ’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of RNAZ in the last 7 days?
      ▼ 3.8% of TipRanks' retail investors changed their holding of RNAZ in the last 7 days.
        What percentage of retail investors changed their holding of RNAZ in the last 30 days?
        ▼ 5.6% of TipRanks' retail investors changed their holding of RNAZ in the last 30 days.
          What is the average age of retail investors who hold RNAZ?
          The average age of RNAZ Holders is under 35.
            What other stocks have RNAZ investors also bought?
            RNAZ Investors also bought RIOT, CHPT, MARA, PLUG, PDD, PATH, GE, VRT, SOUN, LCID.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALNYAlnylam Pharma
              BCRXBioCryst
              CYTKCytokinetics
              DHRDanaher
              EWEdwards Lifesciences
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis